LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 213 filers reported holding LOXO ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,322,000 | -20.8% | 13,593 | -19.6% | 0.34% | -25.3% |
| Q2 2018 | $2,932,000 | +2.2% | 16,903 | -32.0% | 0.46% | -3.3% |
| Q1 2018 | $2,869,000 | -33.7% | 24,865 | -47.1% | 0.48% | -16.9% |
| Q3 2017 | $4,329,000 | -27.2% | 46,993 | -36.6% | 0.58% | -41.5% |
| Q2 2017 | $5,945,000 | +37.0% | 74,140 | -28.1% | 0.98% | +43.7% |
| Q1 2017 | $4,341,000 | +21.5% | 103,149 | -7.3% | 0.68% | +44.0% |
| Q4 2016 | $3,573,000 | +60.4% | 111,268 | +30.8% | 0.48% | +58.9% |
| Q3 2016 | $2,227,000 | -51.9% | 85,061 | -57.4% | 0.30% | -57.0% |
| Q2 2016 | $4,630,000 | -21.2% | 199,730 | -7.0% | 0.70% | -24.3% |
| Q1 2016 | $5,874,000 | +88.0% | 214,859 | +95.6% | 0.92% | +124.7% |
| Q4 2015 | $3,125,000 | +45.9% | 109,855 | -10.4% | 0.41% | +20.6% |
| Q3 2015 | $2,142,000 | +54.7% | 122,552 | +59.6% | 0.34% | +109.3% |
| Q2 2015 | $1,385,000 | – | 76,807 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
| Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
| DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
| Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
| Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
| Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
| AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
| Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
| EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |